chemoradiation therapy Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)
Any (2)

Phase 3 (1)
Unknown (2)

Interventional (2)
Observational (1)

Chongqing University Cancer Hospital (1)
Merck Sharp & Dohme Corp. (1)
Sunnybrook Health Sciences Centre (1)

No (3)

No (3)

Adult (18+) (3)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadhead and neck carcinoma

I am/have/hadsmall cell lung cancer

I am/have/hadpulmonary function tests

I am/have/hadstage iii non-small cell lung cancer

I am/have/hadmeasurable disease

I am/have/hadneutrophil count

I am/have/hadhead and neck cancer

I am/have/hadadenosquamous carcinoma

I am/have/hadchemoradiation therapy

I am/have/hadadjuvant chemotherapy

I am/have/hadcarcinoma

I am/have/hadlung neoplasm

I am/have/hadcervical cancer stage

I am/have/hadsquamous cell carcinoma

I am/have/hadpulmonary function test

I am/have/hadlung cancer

I am/have/hadrenal function test

I am/have/hadnon-small cell lung cancer

I am/have/hadadjuvant therapy

I am/have/hadstage iv non-small cell lung cancer

added new label for I am/have/had

I am looking for

I am looking forcarboplatin

I am looking forimmunomodulator

I am looking forimmunomodulators

I am looking forcisplatin

I am looking fordurvalumab

I am looking forolaparib

I am looking foretoposide

I am looking forpaclitaxel

I am looking forpemetrexed

I am looking foradjuvant

I am looking forpembrolizumab

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

The primary hypotheses are: Pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab with olaparib is superior to concurrent chemoradiation therapy followed by durvalumab with respect to progression-free survival (PFS) and overall survival (OS) pembrolizumab with concurrent chemoradiation therapy followed by pembrolizumab is superior to concurrent chemoradiation therapy followed by durvalumab …

carboplatin

small cell lung cancer

immunomodulator

stage iii non-small cell lung cancer

pulmonary function tests

0 views
19 Feb, 2024

The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer

The aim of this trial was to evaluate the efficacy of adjuvant chemotherapy in the locally advanced cervical cancer with residual lesions after concurrent chemoradiation therapy.

immunomodulator

chemoradiotherapy

cervical cancer

carcinoma

cisplatin

0 views
19 Feb, 2024

Pilot Study to Evaluate Photoacoustic Imaging in Head and Neck Cancer

Our objective in this pilot study will be to evaluate if PA parameters change within the lymph node involvements during chemoradiation therapy over time. Our hope is to use this information to correlate the changes in measured PA parameters with radiological response.

renal function test

head and neck carcinoma

chemoradiotherapy

neck cancer

measurable disease

0 views
19 Feb, 2024